|
| Status |
Public on May 13, 2020 |
| Title |
Persistence of inflammatory phenotype in residual psoriasic plaques in patients on effective biologic therapy |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
The goal of our study is to elucidate mechanisms of plaque persistence despite overall good drug response.
|
| |
|
| Overall design |
RNA-seq of cross sectional cohort of psoriasic patients and healthy controls
|
| |
|
| Contributor(s) |
Smith KM |
| Citation(s) |
31715177 |
| Submission date |
Jun 04, 2019 |
| Last update date |
May 13, 2020 |
| Contact name |
Kathleen Marie Smith |
| E-mail(s) |
kathleen.m.smith@abbvie.com
|
| Phone |
6172524823
|
| Organization name |
AbbVie
|
| Department |
Systems Computational Biology
|
| Street address |
200 Sidney Street
|
| City |
Cambridge |
| State/province |
MA |
| ZIP/Postal code |
02139 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL21290 |
Illumina HiSeq 3000 (Homo sapiens) |
|
| Samples (93)
|
|
| Relations |
| BioProject |
PRJNA546294 |
| SRA |
SRP200425 |
Less...
More...